Literature DB >> 24712297

Comparative study of the perceived quality of life of patients in treatment for cocaine and heroin dependence in Spain: differences by gender and time in treatment.

Claudia Cristina Morales-Manrique1, Sófía Tomás-Dols, María Zarza-González, Antonio Vidal-Infer, F Javier Alvarez, Juan C Valderrama-Zurián.   

Abstract

This is a cross-sectional study in which we compared the perceived quality of life (QoL) of patients receiving outpatient treatment for cocaine (n = 727) and heroin dependence (n = 469), by analyzing differences by gender and time in treatment. Participants were recruited from addictive behavior centers in Spain in 2004. The World Health Organization Quality of Life Assessment Instrument (WHOQOL-Bref) was used as a measure. Analysis of covariance and multivariate linear regression were used. This study shows the relevance of considering the role of gender in QoL studies, and the need to evaluate the effectiveness of treatment in the improvement of QoL. Limitations of the study were noted.

Entities:  

Keywords:  cocaine-related disorders; gender; opioid-related disorders; quality of life; therapy; treatment outcome

Mesh:

Year:  2014        PMID: 24712297     DOI: 10.3109/10826084.2014.880482

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  3 in total

Review 1.  Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder.

Authors:  Andrew S Huhn; Meredith S Berry; Kelly E Dunn
Journal:  Am J Addict       Date:  2019-05-26

2.  Systematic review of sex-based differences in opioid-based effects.

Authors:  Andrew S Huhn; Meredith S Berry; Kelly E Dunn
Journal:  Int Rev Psychiatry       Date:  2018-12-06

3.  The impact of oral health conditions, socioeconomic status and use of specific substances on quality of life of addicted persons.

Authors:  Tais Cristina Nascimento Marques; Karin Luciana Migliato Sarracini; Karine Laura Cortellazzi; Fábio Luiz Mialhe; Marcelo de Castro Meneghim; Antonio Carlos Pereira; Glaucia Maria Bovi Ambrosano
Journal:  BMC Oral Health       Date:  2015-03-20       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.